NEXTRNA THERAPEUTICS
NextRNA Therapeutics creates targeted therapeutics with the aim of discovering novel ncRNAs that cause disease. The company was founded in 2020 and is headquartered in Cambridge, Massachusetts.
NEXTRNA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2020-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.nextrnatx.com
Total Employee:
11+
Status:
Active
Total Funding:
56.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon WordPress Font Awesome Mobile Non Scaleable Content Sitelinks Search Box Euro Yoast WordPress SEO Plugin Yoast SEO Premium
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Seres Therapeutics
Seres Therapeutics is a microbiome therapeutics company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Evans Capital
Evans Capital investment in Series A - NextRNA Therapeutics
Lightchain Capital
Lightchain Capital investment in Series A - NextRNA Therapeutics
Circle Squared Alternative Investments
Circle Squared Alternative Investments investment in Series A - NextRNA Therapeutics
Cobro Ventures
Cobro Ventures investment in Series A - NextRNA Therapeutics
Jefferies
Jefferies investment in Series A - NextRNA Therapeutics
Rivas Capital
Rivas Capital investment in Series A - NextRNA Therapeutics
Willett Advisors LLC
Willett Advisors LLC investment in Series A - NextRNA Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-11 | NextRNA Therapeutics Names Dominique Verhelle as CEO and Expands Leadership Team |
Official Site Inspections
http://www.nextrnatx.com Semrush global rank: 4.54 M Semrush visits lastest month: 2.31 K
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "NextRNA Therapeutics"
NextRNA Therapeutics - LinkedIn
NextRNA Therapeutics, Inc. is a Boston-based biotechnology company leading the next revolution of RNA-directed therapeutics. Our focus is on identifying and drugging long non-coding RNAs (lncRNAs ...See details»
NextRNA Therapeutics - Crunchbase Company Profile & Funding
NextRNA Therapeutics creates targeted therapeutics with the aim of discovering novel ncRNAs that cause disease. The company was founded in 2020 and is headquartered in Cambridge, …See details»
NextRNA Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Www.nextrnatx.com. Holding Company | 2020 | Massachusetts, United States | 10-50 | www.nextrnatx.com. Last update 08 Mar 2025. Overview. Pipeline. Deal. Translational …See details»
NextRNA Therapeutics - Overview, News & Similar companies
NextRNA Therapeutics contact info: Phone number: (617) 412-6117 Website: www.nextrnatx.com What does NextRNA Therapeutics do? Founded in 2021, NextRNA is a biotechnology …See details»
NextRNA Therapeutics Company Overview, Contact Details
Nextrnatx received financing of $9.3M in Seed on Mar 1st '22. NextRNA Therapeutics, a Cambridge, Mass.-based biotechnology company unlocking the potential of non-coding RNAs …See details»
NextRNA Therapeutics - VentureRadar
"NextRNA Therapeutics was founded in 2020 to pursue non-coding RNAs (ncRNAs) as a new class of therapeutic target. Originally developed in the Novina Lab at the Dana-Farber Cancer …See details»
NextRNA Therapeutics: Contact Details and Business Profile
Nextrnatx.com; 4 619607XXXX; 858509XXXX; 858455XXXX; 617585XXXX; Jason Katz VP, Head of Drug Discovery at NextRNA Therapeutics Boston, MA, US View. 1 nextrnatx.com; 1 …See details»
About Us - NextRNA
During her tenure from 2007 to 2019, she scaled the organization through all stages of growth, optimized HR processes, managed compliance programs, and oversaw the company’s safety …See details»
NextRNA 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for NextRNA. Use the PitchBook Platform to explore the full profile.See details»
NextRNA Therapeutics | Startup Profile and Investments
Nextrnatx.com NextRNA Therapeutics - Company Details NextRNA Therapeutics, Inc. is a Massachusetts-based biotechnology startup founded in 2020, focused on driving the next …See details»
NextRNA - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 28, 2025 NextRNA - Developer of RNA-targeted therapeutics for multiple areas. Raised a total funding of $56.1M over 2 rounds from 7 investors. Founded by Leon Wert Lamas and …See details»
Join Us - NextRNA
Our Values. Our values ground us in our efforts to translate pioneering science into transformative therapeutics to benefit patients and guide us as we strive to have a positive impact on our …See details»
NextRNA Therapeutics | VentureRadar
Website: https://www.nextrnatx.com. Develops therapeutic solutions by unlocking non-coding RNA potential, focusing on long non-coding RNAs, targeting oncology, immunology, and …See details»
NextRNA Therapeutics Expands Executive Team with Appointment …
Smith brings over 20 years of drug discovery and development experience and leadership with a focus on first-in-class targeted small molecule medicines Smith will lead NextRNA’s R&D …See details»
News & Media - NextRNA
Sep 22, 2022 Bayer and NextRNA Therapeutics enter strategic collaboration to develop small molecules targeting long non-coding RNAs (lncRNAs) in OncologySee details»
NextRNA Therapeutics - GitHub
Wf-nf-clipseq_single_end Public Forked from NextRNAtx/clipseq CLIP sequencing analysis pipeline for QC, pre-mapping, genome mapping, UMI deduplication, and multiple peak-calling …See details»
Our Science - NextRNA
What are long non-coding RNAs (lncRNAs)? Approximately 75% of the genome is transcribed into RNAs that do not encode proteins, called non-coding RNAs (ncRNAs). long non-coding RNAs …See details»
NextRNA Therapeutics Email Format | nextrnatx.com Emails
The most common NextRNA Therapeutics email format. is [first] (ex. [email protected]), which is being used by 100.0% of NextRNA Therapeutics work email addresses. NextRNA …See details»
Governor Abbott Announces NTxBio Facility In Plano
4 days ago Office of the Texas Governor. P.O. Box 12428 Austin Texas 78711 (512) 463-2000See details»
Shana Mendozza - NextRNA
Aug 12, 2024 Shana Mendozza is the Executive Director of Human Resources at NextRNA, leading all aspects of HR, with a focus on the growth and development of both the people and …See details»